Related Experiment Video
Updated: Aug 3, 2026

Surface Functionalization of Hepatitis E Virus Nanoparticles Using Chemical Conjugation Methods
Published on: May 11, 2018
Upstream and Downstream Processes for Viral Nanoplexes as Vaccines
Keven Lothert1, Gregor Dekevic1, Daniel Loewe1
1Institute of Bioprocess Engineering and Pharmaceutical Technology (IBPT), Technische Hochschule Mittelhessen (THM) - University of Applied Sciences, Giessen, Germany.
Efficient production of viral nanoplexes for medical applications requires optimized upstream and downstream processes. This study details a bioreactor-based method combined with filtration and chromatography for high-yield virus particle manufacturing.
Area of Science:
- Biotechnology
- Virology
- Process Engineering
Background:
- Viral nanoplexes (viruses, virus-like particles) are crucial for vaccines, gene therapy, and oncolytic agents.
- Efficient production is essential due to increasing medical interest and diverse applications.
- Current processes require optimization for yield, speed, and cost-effectiveness.
Purpose of the Study:
- To outline a combined process for efficient virus particle production.
- To detail a platform-based purification strategy for viral nanoplexes.
- To provide analytical methods for virus characterization and contaminant assessment.
Main Methods:
- Utilizing a stirred tank bioreactor for controlled upstream production.
- Implementing filtration-based clarification for initial purification.
- Employing steric exclusion chromatography for downstream processing.
- Incorporating off-line analytics for characterization and quantification.
Main Results:
- Demonstrates a method for successful virus particle production in a bioreactor.
- Validates a purification approach combining filtration and chromatography.
- Provides a framework for analytical characterization and contaminant monitoring.
Conclusions:
- The described process enables efficient production and purification of viral nanoplexes.
- Optimized upstream and downstream processing is key to meeting medical demands.
- Integrated analytical methods ensure product quality and safety.
More Related Videos
10:58Production of E. coli-expressed Self-Assembling Protein Nanoparticles for Vaccines Requiring Trimeric Epitope Presentation
Published on: August 21, 2019
08:27Synthesis and Characterization of mRNA-Loaded PolyBeta Aminoesters Nanoparticles for Vaccination Purposes
Published on: August 13, 2021